News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
MELINTA THERAPEUTICS ANNOUNCES COMMERCIAL AVAILABILITY OF REZZAYO™ (rezafungin for injection)
July 31, 2023 Press Release New Treatment for Candidemia and Invasive Candidiasis Now Available in the U.S PARSIPPANY, NJ, July 31, 2023 –Melinta Therapeutics, LLC today announced the availability
Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics for Use in Pediatric Patients, and for Use Against Biothreat Pathogens
July 10, 2023 Press Release Parsippany, NJ – Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today
Melinta Therapeutics and Xediton Pharmaceuticals Announce Licensing Agreement to Commercialize Anti-Infective Products in Canada
May 15, 2023 Press Release Parsippany, New Jersey and Ontario, Canada, May 15, 2023 – Melinta Therapeutics, LLC (Melinta) and Xediton Pharmaceuticals Inc (Xediton) today announced they have entered